DOC
SLIDES
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Home
›
Search Results for "clinical endpoints"
Search Results for 'clinical endpoints'
clinical endpoints published presentations and documents on DocSlides.
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
by SugarPlumFairy
FDA Perspective. Marco Cannella, PhD. Senior Lead ...
Positive Impacts of Developing Novel Endpoints
by ryotheasy
Generated by Mobile Technology for . Use in Clinic...
Pragmatic Clinical Trials: Challenges with Clinical Event Ascertainment using
by anastasia
RWD. Frank W. Rockhold, PhD. Professor of Biostati...
Session I: DHT-Derived Novel Endpoint Development: Current Landscape
by deborah
Elektra Papadopoulos, . FDA/CDER. Lindsay Kehoe, ....
End-points utilized in
by marina-yarberry
End-points utilized in breast cancer clinical ...
Analysis of Multiple End Points in Clinical trials
by roberts
. By . Trusha Patel and Sirisha . Davuluri. “An ...
Wound Care Collaborative Community
by clara
Member Meeting January 4, 2022. 0. Agenda- . Welc...
An investigation into the two-stage meta-analytic copula modelling approach for evaluating time-to-
by elyana
. Natalie Dimier and Sue Todd. University of Readi...
Regulatory aspects and review
by mary
of EMA authorized . biosimilars. Session “Biosim...
End-points utilized in breast cancer
by evelyn
clinical . trials - Discussion. Novartis Oncology...
Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
by victoria
Raye Z. Litten, Ph.D.. Daniel Falk, Ph.D. (Discuss...
Clinical 101: Clinical trial endpoints:
by sherrill-nordquist
Selection. , analysis and interpretation. Elizabe...
Evaluating an Adaptive Clinical Trial with Quantitative Endpoints, Sample Size Re-estimation, Seque
by kaysen
By: Harrison . Reeder. Mentor: Dr. Kathryn . Chalo...
Critical Issues in the Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
by byrne
Daniel Falk, Ph.D. (Discussant). Division of Treat...
Biomarkers A biological marker is
by madison
a measurable indicator . that . can . tell . us so...
“Stronger Together We are”
by faustina-dinatale
Daniel J. Sargent, PhD. 1970-2016. Wore Many hats...
Thierry Le Chevalier, MD
by aaron
How . d. o . International Regulatory Groups View...
Exploration of Endpoints for Pivotal Clinical Trials to Tre
by yoshiko-marsland
Raye Z. Litten, Ph.D.. Daniel Falk, Ph.D. (Discus...
Thierry Le Chevalier, MD
by yoshiko-marsland
How . d. o International Regulatory Groups View C...
Three-year clinical and echocardiographic follow-up of aort
by briana-ranney
Sabine . Bleiziffer. . German Heart Center, Muni...
Results of DEFUSE Clinical Endpoints International St
by natalia-silvester
Lansberg MD PhD No Relevant Disclosures On behalf...
Guidelines for Endpoints in Animal Study ProposalsIntroductionEndpoint
by briana-ranney
1 2 Clinical observations used in cancer research ...
Accessing the Accelerated Approval Pathway with a Rare Neur
by karlyn-bohler
Batten Disease. June 29-30, 2010 . FDA Public Mee...
Rationale for New Drugs for Tuberculosis
by pamella-moone
500,000 cases annually of MDR TB. Second line tre...
Guidance for Industry
by faustina-dinatale
Clinical Trial Endpoints Center for Drug Evaluatio...
Statistical issues:
by conchita-marotz
Designing your trial for success. Elizabeth Garre...
Digital Health Learning & Clinical Effectiveness Research Collaboratives
by acenum
May 22, 2019. Journal Editor Perspectives. Joseph ...
White Paper S
by harmony
trengthening the Accelerated Approval Pathway1STRE...
Introduction, Meeting Objectives and roadmap
by jaxson
Roy Freeman, MD. Professor of Neurology, Harvard M...
Barriers to and Recommendations for Adoption of
by mitsue-stanley
Barriers to and Recommendations for Adoption of DH...
Load More...